Procedures
schizophrenia
SYNDROME, POSITIVE
Baseline data collection took place in September and October of 2019, the intervention was delivered from November 2019 to February 2020, and immediate post-intervention follow-up data collection occurred from March through June of 2020. Written informed consent was obtained from all participants after being screened for study eligibility. Individuals living with schizophrenia were required to be stable at the time of consent, which was determined by the study psychiatrists. To ensure that these individuals were able to give adequate informed consent, the research team revisited the consent form with them prior to the follow-up interview. All participants were compensated 7,500 Tsh (~ $3.50 USD) at each interview for costs related to study attendance.Study visits and data collection occurred in office facilities within MNH and MZRH. Research assistants administered all patient interviews with self-reported assessment measures, including sociodemographic information, except for the clinician-rated measure, the Positive and Negative Syndrome Scale (PANSS) [